Synthesis and in vitro anticancer studies of arene ruthenium(II) and arene osmium(II) complexes bearing arsine and stibine co-ligands on breast cancer cell-lines

The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity

(2021) Serah Kimani et al.   BIOCHEMICAL PHARMACOLOGY

Osmium Arene Germyl, Stannyl, Germanate, and Stannate Complexes as Anticancer Agents

(2021) Tomiris Nabiyeva et al.   ACS Omega

Synthesis, structure and anti-cancer activity of osmium complexes bearing π-bound arene substituents and phosphane Co-Ligands: A review

(2020) Tomiris Nabiyeva et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Facile entry to germanate and stannate complexes [(η6-arene)RuCl(η2-dppm)]+[ECl3]- (E = Ge, Sn) as potent anti-cancer agents

(2020) Niccolo Aldeghi et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives

(2020) Sang Yeul Lee et al.   Drug Design Development and Therapy

Ionic Ruthenium and Iron Based Complexes Bearing Silver Containing Anions as a Potent New Class of Anticancer Agents

(2020) Amal Benamrane et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Modulation of the solubility properties of arene ruthenium complexes bearing stannyl ligands as potential anti-cancer agents

(2019) Clara Berg et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Synthesis, Characterisation and Cytotoxicity Studies of Ruthenium Arene Complexes Bearing Trichlorogermyl Ligands

(2018) Connor Deacon-Price et al.   INORGANICA CHIMICA ACTA

Role of the Trichlorostannyl Ligand in Tin-Ruthenium Arene Complexes: Experimental and Computational Studies

(2017) Miroslav Novák et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Ruthenium(III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3/AsPh3 coligand: Synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities

(2014) Govindan Prakash et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

Considerations regarding use of solvents in in vitro cell based assays

(2013) Michael Timm et al.   CYTOTECHNOLOGY

Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: Impact of oxidation state and co-ligands on anticancer activity in vitro

(2011) Thangavel Sathiya Kamatchi et al.   DALTON TRANSACTIONS

Aquation and dimerization of osmium(ii) anticancer complexes: a density functional theory study

(2011) Hanlu Wang et al.   RSC Advances

Anticancer activity of new organo-ruthenium, rhodium and iridium complexes containing the 2-(pyridine-2-yl)thiazole N,N-chelating ligand

(2010) Michaël Gras et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Areneruthenium complexes as anticancer agents

(2009) Georg Süss-Fink   DALTON TRANSACTIONS

Perspectives of antimony compounds in oncology

(2008) Pankaj SHARMA et al.   ACTA PHARMACOLOGICA SINICA